CPC extracts products with nearly 100 percent purity at a 95 percent recovery rate and as such could be used to research, develop and produce cannabis-derived medicines.
The changes concern the reclassification of cannabis to make it a schedule 2 drug, allowing it to be prescribed by medical professionals and possessed lawfully by anybody with a valid medical prescription.
The accurate detection of microbial contamination is key to protecting consumer safety and, helping to reduce the environmental burden of pesticide use in the cannabis industry.
Novel sample prep blend enables an average recovery of 75.6% for 48 pesticides and 4 mycotoxins whilst also removing purple pigmentation from cannabis samples.
A combination of THCA and CBGA can interact synergistically to cause distinct gene expression, induction of cell cycle arrest, and apoptotic cell death in colon cancer cells.
Ion mobility spectroscopy has the potential to be a suitable portable analysis technique that could be used in the field as itis small, portable, and simple to use.
The reduction in monoterpene content has implications for those who seek the reported beneficial synergistic effects of cannabinoids and terpenes.
Examining a broad array of cannabinoids and terpenes reveals the inherent failings of commonly used cannabis classification systems.
The cannabis industry has largely escaped negligence cases to date, mainly due to legal uncertainties - experts claim this ‘tort cease-fire’ is coming to an end.